![8NR 8NR](https://data.pdbj.org/pdbjplus/data/cc/svg/8NR.svg) | 8NR | Name: | ethyl 4-(5,6,7,8-tetrahydroacridin-3-ylcarbonyl)piperazine-1-carboxylate | Formula: | C21 H25 N3 O3 | SMILES: | CCOC(=O)N1CCN(CC1)C(=O)c2ccc3cc4CCCCc4nc3c2 | InChi: | InChI=1S/C21H25N3O3/c1-2-27-21(26)24-11-9-23(10-12-24)20(25)17-8-7-16-13-15-5-3-4-6-18(15)22-19(16)14-17/h7-8,13-14H,2-6,9-12H2,1H3 | Definition date: | 2017-08-14 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | ethyl 4-(5,6,7,8-tetrahydroacridin-3-ylcarbonyl)piperazine-1-carboxylate |
|
![8QL 8QL](https://data.pdbj.org/pdbjplus/data/cc/svg/8QL.svg) | 8QL | Name: | (3S,6S,8S,9S,10R,13S,14R)-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6-diol | Formula: | C19 H30 O2 | SMILES: | C[C]12CCC[CH]1[CH]3C[CH](O)C4=C[CH](O)CC[C]4(C)[CH]3CC2 | InChi: | InChI=1S/C19H30O2/c1-18-7-3-4-14(18)13-11-17(21)16-10-12(20)5-9-19(16,2)15(13)6-8-18/h10,12-15,17,20-21H,3-9,11H2,1-2H3/t12-,13-,14+,15-,17-,18-,19+/m0/s1 | Definition date: | 2017-08-25 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | (3~{S},6~{S},8~{S},9~{S},10~{R},13~{S},14~{R})-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1~{H}-cyclopenta[a]phenanthrene-3,6-diol |
|
![BNQ BNQ](https://data.pdbj.org/pdbjplus/data/cc/svg/BNQ.svg) | BNQ | Name: | ~{N}-(1,3-benzothiazol-2-yl)-3,3-diphenyl-propanamide | Formula: | C22 H18 N2 O S | SMILES: | O=C(CC(c1ccccc1)c2ccccc2)Nc3sc4ccccc4n3 | InChi: | InChI=1S/C22H18N2OS/c25-21(24-22-23-19-13-7-8-14-20(19)26-22)15-18(16-9-3-1-4-10-16)17-11-5-2-6-12-17/h1-14,18H,15H2,(H,23,24,25) | Definition date: | 2017-10-11 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | ~{N}-(1,3-benzothiazol-2-yl)-3,3-diphenyl-propanamide |
|
![BSV BSV](https://data.pdbj.org/pdbjplus/data/cc/svg/BSV.svg) | BSV | Name: | (2Z)-4-(5-cyclopropyl-2-methylphenyl)-2-hydroxy-4-oxobut-2-enoic acid | Formula: | C14 H14 O4 | SMILES: | C(/C(c1c(C)ccc(c1)C2CC2)=O)=C(C(O)=O)O | InChi: | InChI=1S/C14H14O4/c1-8-2-3-10(9-4-5-9)6-11(8)12(15)7-13(16)14(17)18/h2-3,6-7,9,16H,4-5H2,1H3,(H,17,18)/b13-7- | Definition date: | 2017-08-24 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | (2Z)-4-(5-cyclopropyl-2-methylphenyl)-2-hydroxy-4-oxobut-2-enoic acid |
|
![BVS BVS](https://data.pdbj.org/pdbjplus/data/cc/svg/BVS.svg) | BVS | Name: | (2Z)-2-hydroxy-4-(4-methylphenyl)-4-oxobut-2-enoic acid | Formula: | C11 H10 O4 | SMILES: | C(/C(c1ccc(C)cc1)=O)=C(C(O)=O)O | InChi: | InChI=1S/C11H10O4/c1-7-2-4-8(5-3-7)9(12)6-10(13)11(14)15/h2-6,13H,1H3,(H,14,15)/b10-6- | Definition date: | 2017-08-28 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | (2Z)-2-hydroxy-4-(4-methylphenyl)-4-oxobut-2-enoic acid |
|
![BXT BXT](https://data.pdbj.org/pdbjplus/data/cc/svg/BXT.svg) | BXT | Name: | (2~{S})-2-azanyl-3-[ethyl(methyl)carbamoyl]oxy-propanoic acid | Formula: | C7 H14 N2 O4 | SMILES: | CCN(C)C(=O)OC[CH](N)C(O)=O | InChi: | InChI=1S/C7H14N2O4/c1-3-9(2)7(12)13-4-5(8)6(10)11/h5H,3-4,8H2,1-2H3,(H,10,11)/t5-/m0/s1 | Definition date: | 2017-10-30 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | (2~{S})-2-azanyl-3-[ethyl(methyl)carbamoyl]oxy-propanoic acid |
|
![DQ5 DQ5](https://data.pdbj.org/pdbjplus/data/cc/svg/DQ5.svg) | DQ5 | Name: | 2-[(~{E})-hydroxyiminomethyl]-6-[4-(1,2,3,4-tetrahydroacridin-9-ylamino)butyl]pyridin-3-ol | Formula: | C23 H26 N4 O2 | SMILES: | ON=Cc1nc(CCCCNc2c3CCCCc3nc4ccccc24)ccc1O | InChi: | InChI=1S/C23H26N4O2/c28-22-13-12-16(26-21(22)15-25-29)7-5-6-14-24-23-17-8-1-3-10-19(17)27-20-11-4-2-9-18(20)23/h1,3,8,10,12-13,15,28-29H,2,4-7,9,11,14H2,(H,24,27)/b25-15+ | Definition date: | 2018-01-26 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | 2-[(~{E})-hydroxyiminomethyl]-6-[4-(1,2,3,4-tetrahydroacridin-9-ylamino)butyl]pyridin-3-ol |
|
![E2T E2T](https://data.pdbj.org/pdbjplus/data/cc/svg/E2T.svg) | E2T | Name: | ~{N}-[3-(2,5-dimethyl-3-oxidanylidene-1,2-oxazol-4-yl)-5-(5-ethanoyl-2-ethoxy-phenyl)phenyl]furan-2-carboxamide | Formula: | C26 H24 N2 O6 | SMILES: | CCOc1ccc(cc1c2cc(NC(=O)c3occc3)cc(c2)C4=C(C)ON(C)C4=O)C(C)=O | InChi: | InChI=1S/C26H24N2O6/c1-5-32-22-9-8-17(15(2)29)14-21(22)18-11-19(24-16(3)34-28(4)26(24)31)13-20(12-18)27-25(30)23-7-6-10-33-23/h6-14H,5H2,1-4H3,(H,27,30) | Definition date: | 2018-02-14 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | ~{N}-[3-(2,5-dimethyl-3-oxidanylidene-1,2-oxazol-4-yl)-5-(5-ethanoyl-2-ethoxy-phenyl)phenyl]furan-2-carboxamide |
|
![E2W E2W](https://data.pdbj.org/pdbjplus/data/cc/svg/E2W.svg) | E2W | Name: | 6-[4-[(7-chloranyl-1,2,3,4-tetrahydroacridin-9-yl)amino]butyl]-2-[(oxidanylamino)methyl]pyridin-3-ol | Formula: | C23 H27 Cl N4 O2 | SMILES: | ONCc1nc(CCCCNc2c3CCCCc3nc4ccc(Cl)cc24)ccc1O | InChi: | InChI=1S/C23H27ClN4O2/c24-15-8-10-20-18(13-15)23(17-6-1-2-7-19(17)28-20)25-12-4-3-5-16-9-11-22(29)21(27-16)14-26-30/h8-11,13,26,29-30H,1-7,12,14H2,(H,25,28) | Definition date: | 2018-02-14 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | 6-[4-[(7-chloranyl-1,2,3,4-tetrahydroacridin-9-yl)amino]butyl]-2-[(oxidanylamino)methyl]pyridin-3-ol |
|
![E3B E3B](https://data.pdbj.org/pdbjplus/data/cc/svg/E3B.svg) | E3B | Name: | 1-[3-[3-[3,3-bis(fluoranyl)piperidin-1-yl]phenyl]-4-ethoxy-phenyl]ethanone | Formula: | C21 H23 F2 N O2 | SMILES: | CCOc1ccc(cc1c2cccc(c2)N3CCCC(F)(F)C3)C(C)=O | InChi: | InChI=1S/C21H23F2NO2/c1-3-26-20-9-8-16(15(2)25)13-19(20)17-6-4-7-18(12-17)24-11-5-10-21(22,23)14-24/h4,6-9,12-13H,3,5,10-11,14H2,1-2H3 | Definition date: | 2018-02-15 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | 1-[3-[3-[3,3-bis(fluoranyl)piperidin-1-yl]phenyl]-4-ethoxy-phenyl]ethanone |
|
![E3H E3H](https://data.pdbj.org/pdbjplus/data/cc/svg/E3H.svg) | E3H | Name: | ~{N}-[3-(5-ethanoyl-2-ethoxy-phenyl)-5-(2-ethyl-5-methyl-3-oxidanylidene-1,2-oxazol-4-yl)phenyl]furan-2-carboxamide | Formula: | C27 H26 N2 O6 | SMILES: | CCOc1ccc(cc1c2cc(NC(=O)c3occc3)cc(c2)C4=C(C)ON(CC)C4=O)C(C)=O | InChi: | InChI=1S/C27H26N2O6/c1-5-29-27(32)25(17(4)35-29)20-12-19(13-21(14-20)28-26(31)24-8-7-11-34-24)22-15-18(16(3)30)9-10-23(22)33-6-2/h7-15H,5-6H2,1-4H3,(H,28,31) | Definition date: | 2018-02-15 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | ~{N}-[3-(5-ethanoyl-2-ethoxy-phenyl)-5-(2-ethyl-5-methyl-3-oxidanylidene-1,2-oxazol-4-yl)phenyl]furan-2-carboxamide |
|
![E3T E3T](https://data.pdbj.org/pdbjplus/data/cc/svg/E3T.svg) | E3T | Name: | ~{N}-[3-(3,5-dimethyl-1,2-oxazol-4-yl)-5-(5-ethanoyl-2-ethoxy-phenyl)phenyl]furan-2-carboxamide | Formula: | C26 H24 N2 O5 | SMILES: | CCOc1ccc(cc1c2cc(NC(=O)c3occc3)cc(c2)c4c(C)onc4C)C(C)=O | InChi: | InChI=1S/C26H24N2O5/c1-5-31-23-9-8-18(16(3)29)14-22(23)19-11-20(25-15(2)28-33-17(25)4)13-21(12-19)27-26(30)24-7-6-10-32-24/h6-14H,5H2,1-4H3,(H,27,30) | Definition date: | 2018-02-16 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | ~{N}-[3-(3,5-dimethyl-1,2-oxazol-4-yl)-5-(5-ethanoyl-2-ethoxy-phenyl)phenyl]furan-2-carboxamide |
|
![ELT ELT](https://data.pdbj.org/pdbjplus/data/cc/svg/ELT.svg) | ELT | Name: | ethoxy-~{N},~{N}-dimethyl-phosphonamidic acid | Formula: | C4 H12 N O3 P | SMILES: | CCO[P](O)(=O)N(C)C | InChi: | InChI=1S/C4H12NO3P/c1-4-8-9(6,7)5(2)3/h4H2,1-3H3,(H,6,7) | Definition date: | 2018-03-28 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | ethoxy-~{N},~{N}-dimethyl-phosphonamidic acid |
|
![B5T B5T](https://data.pdbj.org/pdbjplus/data/cc/svg/B5T.svg) | B5T | Name: | 4-(3-pyridin-3-yl-1~{H}-pyrrolo[2,3-b]pyridin-5-yl)benzenesulfonamide | Formula: | C18 H14 N4 O2 S | SMILES: | N[S](=O)(=O)c1ccc(cc1)c2cnc3[nH]cc(c4cccnc4)c3c2 | InChi: | InChI=1S/C18H14N4O2S/c19-25(23,24)15-5-3-12(4-6-15)14-8-16-17(11-22-18(16)21-10-14)13-2-1-7-20-9-13/h1-11H,(H,21,22)(H2,19,23,24) | Definition date: | 2017-09-19 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | 4-(3-pyridin-3-yl-1~{H}-pyrrolo[2,3-b]pyridin-5-yl)benzenesulfonamide |
|
![B5Z B5Z](https://data.pdbj.org/pdbjplus/data/cc/svg/B5Z.svg) | B5Z | Name: | ~{N}-[5-[3-(2-morpholin-4-ylethylcarbamoylamino)phenyl]-[1,3]thiazolo[5,4-b]pyridin-2-yl]cyclopropanecarboxamide | Formula: | C23 H26 N6 O3 S | SMILES: | O=C(NCCN1CCOCC1)Nc2cccc(c2)c3ccc4nc(NC(=O)C5CC5)sc4n3 | InChi: | InChI=1S/C23H26N6O3S/c30-20(15-4-5-15)28-23-27-19-7-6-18(26-21(19)33-23)16-2-1-3-17(14-16)25-22(31)24-8-9-29-10-12-32-13-11-29/h1-3,6-7,14-15H,4-5,8-13H2,(H2,24,25,31)(H,27,28,30) | Definition date: | 2017-09-19 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | ~{N}-[5-[3-(2-morpholin-4-ylethylcarbamoylamino)phenyl]-[1,3]thiazolo[5,4-b]pyridin-2-yl]cyclopropanecarboxamide |
|
![B6B B6B](https://data.pdbj.org/pdbjplus/data/cc/svg/B6B.svg) | B6B | Name: | [3-azanyl-6-(5-azanyl-2-methoxy-phenyl)pyrazin-2-yl]-pyridin-3-yl-methanone | Formula: | C17 H15 N5 O2 | SMILES: | COc1ccc(N)cc1c2cnc(N)c(n2)C(=O)c3cccnc3 | InChi: | InChI=1S/C17H15N5O2/c1-24-14-5-4-11(18)7-12(14)13-9-21-17(19)15(22-13)16(23)10-3-2-6-20-8-10/h2-9H,18H2,1H3,(H2,19,21) | Definition date: | 2017-09-19 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | [3-azanyl-6-(5-azanyl-2-methoxy-phenyl)pyrazin-2-yl]-pyridin-3-yl-methanone |
|
![B6H B6H](https://data.pdbj.org/pdbjplus/data/cc/svg/B6H.svg) | B6H | Name: | ~{N}-[4-[[4-azanyl-2-[[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino]-1,3-thiazol-5-yl]carbonyl]phenyl]propanamide | Formula: | C25 H30 N6 O3 S | SMILES: | CCC(=O)Nc1ccc(cc1)C(=O)c2sc(Nc3ccc(cc3OC)N4CCN(C)CC4)nc2N | InChi: | InChI=1S/C25H30N6O3S/c1-4-21(32)27-17-7-5-16(6-8-17)22(33)23-24(26)29-25(35-23)28-19-10-9-18(15-20(19)34-3)31-13-11-30(2)12-14-31/h5-10,15H,4,11-14,26H2,1-3H3,(H,27,32)(H,28,29) | Definition date: | 2017-09-19 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | ~{N}-[4-[[4-azanyl-2-[[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino]-1,3-thiazol-5-yl]carbonyl]phenyl]propanamide |
|
![B6N B6N](https://data.pdbj.org/pdbjplus/data/cc/svg/B6N.svg) | B6N | Name: | 1-[4-fluoranyl-2-(trifluoromethyl)phenyl]-9-(1~{H}-pyrazol-4-yl)benzo[h][1,6]naphthyridin-2-one | Formula: | C22 H12 F4 N4 O | SMILES: | Fc1ccc(N2C(=O)C=Cc3cnc4ccc(cc4c23)c5c[nH]nc5)c(c1)C(F)(F)F | InChi: | InChI=1S/C22H12F4N4O/c23-15-3-5-19(17(8-15)22(24,25)26)30-20(31)6-2-13-9-27-18-4-1-12(7-16(18)21(13)30)14-10-28-29-11-14/h1-11H,(H,28,29) | Definition date: | 2017-09-19 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | 1-[4-fluoranyl-2-(trifluoromethyl)phenyl]-9-(1~{H}-pyrazol-4-yl)benzo[h][1,6]naphthyridin-2-one |
|
![B6Q B6Q](https://data.pdbj.org/pdbjplus/data/cc/svg/B6Q.svg) | B6Q | Name: | ~{N}-[3-[[4-azanyl-2-[[4-(4-methylpiperazin-1-yl)phenyl]amino]-1,3-thiazol-5-yl]carbonyl]phenyl]propanamide | Formula: | C24 H28 N6 O2 S | SMILES: | CCC(=O)Nc1cccc(c1)C(=O)c2sc(Nc3ccc(cc3)N4CCN(C)CC4)nc2N | InChi: | InChI=1S/C24H28N6O2S/c1-3-20(31)26-18-6-4-5-16(15-18)21(32)22-23(25)28-24(33-22)27-17-7-9-19(10-8-17)30-13-11-29(2)12-14-30/h4-10,15H,3,11-14,25H2,1-2H3,(H,26,31)(H,27,28) | Definition date: | 2017-09-19 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | ~{N}-[3-[[4-azanyl-2-[[4-(4-methylpiperazin-1-yl)phenyl]amino]-1,3-thiazol-5-yl]carbonyl]phenyl]propanamide |
|
![B6Z B6Z](https://data.pdbj.org/pdbjplus/data/cc/svg/B6Z.svg) | B6Z | Name: | [4-azanyl-2-[[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino]-1,3-thiazol-5-yl]-phenyl-methanone | Formula: | C22 H25 N5 O2 S | SMILES: | COc1cc(ccc1Nc2sc(c(N)n2)C(=O)c3ccccc3)N4CCN(C)CC4 | InChi: | InChI=1S/C22H25N5O2S/c1-26-10-12-27(13-11-26)16-8-9-17(18(14-16)29-2)24-22-25-21(23)20(30-22)19(28)15-6-4-3-5-7-15/h3-9,14H,10-13,23H2,1-2H3,(H,24,25) | Definition date: | 2017-09-20 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | [4-azanyl-2-[[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino]-1,3-thiazol-5-yl]-phenyl-methanone |
|
![EVB EVB](https://data.pdbj.org/pdbjplus/data/cc/svg/EVB.svg) | EVB | Name: | sulfonato-calix[8]arene | Formula: | C56 H48 O32 S8 | SMILES: | Oc1c2Cc3cc(cc(Cc4cc(cc(Cc5cc(cc(Cc6cc(cc(Cc7cc(cc(Cc8cc(cc(Cc9cc(cc(Cc1cc(c2)[S](O)(=O)=O)c9O)[S](O)(=O)=O)c8O)[S](O)(=O)=O)c7O)[S](O)(=O)=O)c6O)[S](O)(=O)=O)c5O)[S](O)(=O)=O)c4O)[S](O)(=O)=O)c3O)[S](O)(=O)=O | InChi: | InChI=1S/C56H48O32S8/c57-49-25-1-26-10-42(90(68,69)70)12-28(50(26)58)3-30-14-44(92(74,75)76)16-32(52(30)60)5-34-18-46(94(80,81)82)20-36(54(34)62)7-38-22-48(96(86,87)88)24-40(56(38)64)8-39-23-47(95(83,84)85)21-37(55(39)63)6-35-19-45(93(77,78)79)17-33(53(35)61)4-31-15-43(91(71,72)73)13-29(51(31)59)2-27(49)11-41(9-25)89(65,66)67/h9-24,57-64H,1-8H2,(H,65,66,67)(H,68,69,70)(H,71,72,73)(H,74,75,76)(H,77,78,79)(H,80,81,82)(H,83,84,85)(H,86,87,88) | Definition date: | 2018-04-23 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 |
|
![EX1 EX1](https://data.pdbj.org/pdbjplus/data/cc/svg/EX1.svg) | EX1 | Name: | 2-({2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]phenyl}amino)-5-methyl-11-(propan-2-yl)-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one | Formula: | C33 H42 N8 O3 | SMILES: | C1(CCN(CC1)C(=O)c2ccc(c(OC)c2)Nc5nc3c(N(C(=O)c4c(N3C(C)C)cccc4)C)cn5)N6CCN(CC6)C | InChi: | InChI=1S/C33H42N8O3/c1-22(2)41-27-9-7-6-8-25(27)32(43)38(4)28-21-34-33(36-30(28)41)35-26-11-10-23(20-29(26)44-5)31(42)40-14-12-24(13-15-40)39-18-16-37(3)17-19-39/h6-11,20-22,24H,12-19H2,1-5H3,(H,34,35,36) | Definition date: | 2018-02-08 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | 2-({2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]phenyl}amino)-5-methyl-11-(propan-2-yl)-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one |
|
![F2S F2S](https://data.pdbj.org/pdbjplus/data/cc/svg/F2S.svg) | F2S | Name: | 11-[(2R)-butan-2-yl]-2-({2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]phenyl}amino)-5-methyl-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one | Formula: | C34 H44 N8 O3 | SMILES: | c3(C(N1CCC(CC1)N2CCN(CC2)C)=O)ccc(c(c3)OC)Nc6ncc5N(C(=O)c4c(cccc4)N(C(C)CC)c5n6)C | InChi: | InChI=1S/C34H44N8O3/c1-6-23(2)42-28-10-8-7-9-26(28)33(44)39(4)29-22-35-34(37-31(29)42)36-27-12-11-24(21-30(27)45-5)32(43)41-15-13-25(14-16-41)40-19-17-38(3)18-20-40/h7-12,21-23,25H,6,13-20H2,1-5H3,(H,35,36,37)/t23-/m1/s1 | Definition date: | 2018-02-26 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | 11-[(2R)-butan-2-yl]-2-({2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]phenyl}amino)-5-methyl-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one |
|
![F3J F3J](https://data.pdbj.org/pdbjplus/data/cc/svg/F3J.svg) | F3J | Name: | 11-cyclobutyl-2-({2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]phenyl}amino)-5-methyl-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one | Formula: | C34 H42 N8 O3 | SMILES: | C1C(CCN(C1)C(=O)c2ccc(c(c2)OC)Nc3nc5c(cn3)N(C(=O)c4c(cccc4)N5C6CCC6)C)N7CCN(C)CC7 | InChi: | InChI=1S/C34H42N8O3/c1-38-17-19-40(20-18-38)24-13-15-41(16-14-24)32(43)23-11-12-27(30(21-23)45-3)36-34-35-22-29-31(37-34)42(25-7-6-8-25)28-10-5-4-9-26(28)33(44)39(29)2/h4-5,9-12,21-22,24-25H,6-8,13-20H2,1-3H3,(H,35,36,37) | Definition date: | 2018-02-26 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | 11-cyclobutyl-2-({2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]phenyl}amino)-5-methyl-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one |
|
![FJT FJT](https://data.pdbj.org/pdbjplus/data/cc/svg/FJT.svg) | FJT | Name: | ~{N}-(1,3-benzodioxol-5-ylmethyl)-5-[(2-chloranyl-4-fluoranyl-phenyl)methyl]-1,3,4-oxadiazole-2-carboxamide | Formula: | C18 H13 Cl F N3 O4 | SMILES: | Fc1ccc(Cc2oc(nn2)C(=O)NCc3ccc4OCOc4c3)c(Cl)c1 | InChi: | InChI=1S/C18H13ClFN3O4/c19-13-7-12(20)3-2-11(13)6-16-22-23-18(27-16)17(24)21-8-10-1-4-14-15(5-10)26-9-25-14/h1-5,7H,6,8-9H2,(H,21,24) | Definition date: | 2018-07-13 | Last modified: | 2018-08-24 | Release date: | 2018-08-29 | Identifier: | ~{N}-(1,3-benzodioxol-5-ylmethyl)-5-[(2-chloranyl-4-fluoranyl-phenyl)methyl]-1,3,4-oxadiazole-2-carboxamide |
|